DPP4 and autoimmune disease: Moreover, CD26 deficiency triggers M2 macrophage differentiation [172], and DPP4/CD26 inhibitors can decrease the risk of autoimmune disease occurrence in the course of T2D, as was shown in clinical studies [177].